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Background
Cumulative data indicate that CD4+ Treg and Th17 cells
are reciprocally regulated during differentiation and play
couter balance role in inflammatory diseases, suggesting
the balance of them is critical in maintaining effective
immune function. Loss of such an immuno-balance has
recently been documented in tumors and SIV infection.
However, little data is available on the balance between
Treg and Th17 in chronic HIV-1 infection.
Methods
HARRT naive subjects with chronic HIV-1 infection(n =
80)and HIV-1 negative control were enrolled (n = 24).
Treg were analyzed in FACSCalibur with fresh PBMC,
while Th17 analyzed in PBMC stimulated with PMA/ion-
omycin followed by BFA block. Treg and Th17 levels were
represented as percentages of CD4+CD25hiFoxp3+ cells
and CD4+IL-17A+ cells in CD4+ T population respectively,
and the ratio of Th17 to Treg was used to evaluate the
immuno-balance.
Results
When correlating Treg or Th17 level with CD4+ T cell
counts or plasma viral load, only the inverse association
between Treg and CD4+ T count was significant (r = -
0.462, p < 0.001). Treg levels with CD4+ T counts/μl
below 200 (median = 8.29%, n = 11) was significantly
higher than those above 200 (5.00%, n = 69) or HIV-1
negative control (4.34%, n = 24) (p < 0.001, < 0.001),
while Th17 level in both HIV-1+  subjects with CD4+
counts/μl below 200 (0.79%) or more than 200 (0.63%)
were significantly higher than HIV-1 negative control
(0.30%) (p = 0.011, < 0.001). Th17/Treg ratio was signif-
icantly elevated in HIV-1+ subjects than HIV-1 negative
control (0.1210 v.s. 0.0641, p = 0.002). Notably, elite
controllers (n = 4) have a comparable Treg, Th17 levels
and Th17/Treg ratio with HIV-1 negative control (p =
0.777, = 0.818, = 0.922).
Conclusion
An inproportionally increased peripheral Th17 and Treg
levels leading to elevated Th17/Treg ratio was observed in
subjects chronically infected with HIV-1, suggesting a loss
of immuno-balance in HIV-1 infection. However, the elite
controllers manifested a preservation of such an immuno-
balance, which may shed new light into understanding of
HIV-1 pathogenesis and facilitate vaccine development.
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